GGINX
Price
$14.30
Change
+$0.11 (+0.78%)
Updated
Jun 22 closing price
Net Assets
134.16M
RGFTX
Price
$10.79
Change
+$0.02 (+0.19%)
Updated
Jun 22 closing price
Net Assets
597.75M
Interact to see
Advertisement

GGINX vs RGFTX

GGINX vs RGFTX Comparison Chart in %
View a ticker or compare two or three
VS
GGINX vs. RGFTX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGINX is a Hold and RGFTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGFTX has more cash in the bank: 598M vs. GGINX (134M). RGFTX pays higher dividends than GGINX: RGFTX (3.16) vs GGINX (2.06). GGINX was incepted earlier than RGFTX: GGINX (10 years) vs RGFTX (9 years). GGINX (1.36) is less costly to investors than RGFTX (1.22). RGFTX is a more actively managed with annual turnover of: 71.00 vs. GGINX (19.00). GGINX (0) and RGFTX (0) have matching initial minimum investment requirements. GGINX annual gain was more profitable for investors over the last year : 10.65 vs. RGFTX (10.01). RGFTX return over 5 years is better than : 20.59 vs. GGINX (19.37).
GGINXRGFTXGGINX / RGFTX
Total Expense Ratio0.970.91107%
Annual Report Gross Expense Ratio1.361.22111%
Fund Existence10 years9 years-
Gain YTD10.2519.244111%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets134M598M22%
Annual Yield % from dividends2.063.1665%
Returns for 1 year10.6510.01106%
Returns for 3 years27.2838.7570%
Returns for 5 years19.3720.5994%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLN7.540.61
+8.80%
Silence Therapeutics Plc
RYTM101.444.65
+4.80%
Rhythm Pharmaceuticals
GS1106.379.81
+0.89%
Goldman Sachs Group
FTHM1.03-0.04
-3.74%
Fathom Holdings
SVV9.64-0.51
-5.02%
Savers Value Village